BBBY
36
3
CAG
72
2
MDLZ
73
4
DHI
52
3
LUV
33
4
GIS
75
6
PDCO
44
-2
EQR
27
3
PFG
48
2
MSI
64
4
PX
52
4
WM
65
6
ED
56
11
K
50
6
CTAS
52
2
TROW
35
14
HRB
52
5
MKC
48
7
EXC
58
4
PVH
33
-5
BBBY
36
3
CAG
72
2
MDLZ
73
4
DHI
52
3
LUV
33
4
GIS
75
6
PDCO
44
-2
EQR
27
3
PFG
48
2
MSI
64
4
PX
52
4
WM
65
6
ED
56
11
K
50
6
CTAS
52
2
TROW
35
14
HRB
52
5
MKC
48
7
EXC
58
4
PVH
33
-5
Financhill
Back

Karuna Therapeutics 10K Form

Buy
52

KRTX
Karuna Therapeutics

Last Price:
182.59
Seasonality Move:
21.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KRTX News And Ratings

See the #1 stock for the next 7 days that we like better than KRTX

KRTX Financial Statistics

Sales & Book Value

Annual Sales: $10.64M
Cash Flow: $-79.05M
Price / Cash Flow: 0
Annual Sales: $32.67
Price / Book: 5.65

Profitability

EPS (TTM): -8.72000
Net Income (TTM): $-276.34M
Gross Margin: --
Return on Equity: -37.64%
Return on Assets: -36.1%

Karuna Therapeutics Earnings Forecast

Key Karuna Therapeutics Financial Ratios

  • The Research & Development expenses have been 2,107.61% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of KRTX is -2,597.18% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Karuna Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: KRTX
CUSIP: 48576A
Website: karunatx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 34.02
Quick Ratio: 33.11

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KRTX Technical Analysis vs Fundamental Analysis

Buy
52
Karuna Therapeutics (KRTX) is a Buy

Is Karuna Therapeutics a Buy or a Sell?